Polymyxin B sulfate 10,000 UNT / trimethoprim sulfate 1 mg in mL Ophthalmic Solution
RxNorm 244967
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 244967 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: polymyxin B sulfate 10,000 UNT / trimethoprim sulfate 1 mg in mL Ophthalmic Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Polymyxin B 10000 UNT/ML / trimethoprim 1 mg/ML Ophthalmic Solution
(Atom ID: 12336873)
SYPrescribable
Synonym (SY):
Polymyxin B 10,000 UNT / trimethoprim (as trimethoprim sulfate) 0.1 % Ophthalmic Solution
(Atom ID: 5464260)
SYPrescribable
Synonym (SY):
Polymyxin B 10,000 UNT / trimethoprim 0.1 % Ophthalmic Solution
(Atom ID: 4624174)
SYPrescribable
Synonym (SY):
Polymyxin B 10000 UNT/ML / TMP 1 mg/ML Ophthalmic Solution
(Atom ID: 3853546)
PSNPrescribable
Prescribable Name (PSN):
Polymyxin B sulfate 10,000 UNT / trimethoprim sulfate 1 mg in mL Ophthalmic Solution
(Atom ID: 8700398)
Patient Education
Polymyxin B and Trimethoprim Ophthalmic
Polymyxin B and trimethoprim ophthalmic combination is used to treat bacterial infections of the eye including conjunctivitis (pinkeye; infection of the membrane that covers the outside of the eyeball and the inside of the eyelid) or blepharoconjunctivitis (infection of the membrane that covers the outside of the eyeball and the inside and outer parts of the eyelid). Polymyxin B and trimethoprim are in a class of medications called antibiotics. They work by killing bacteria that cause infections.
[Learn More]
* Please review the disclaimer below.